Please enable JavaScript to continue using this application.

Compare $BIO vs $FTRE | Chartloom

Compare

$BIO vs $FTRE

Bio Rad Laboratories Inc · Fortrea Holdings Inc

BIO

Bio Rad Laboratories Inc

FTRE

Fortrea Holdings Inc

Compare $BIO vs $FTRE

Comparing Bio Rad Laboratories Inc and Fortrea Holdings Inc

BIOBio Rad Laboratories Inc

FTREFortrea Holdings Inc

BIOBio Rad Laboratories Inc

Market cap

$9.80B

P/E (TTM)

44.15x

Forward P/E (NTM)

33.67x

Forward P/S (NTM)

3.70x

Rev growth (TTM)

1.4%

YTD performance

19.9%

52W performance

20.9%

FCF yield

3.6%

FTREFortrea Holdings Inc

Market cap

$1.98B

P/E (TTM)

—

Forward P/E (NTM)

21.43x

Forward P/S (NTM)

0.72x

Rev growth (TTM)

-2.1%

YTD performance

24.0%

52W performance

105.7%

FCF yield

9.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BIO

FTRE

Detailed metrics comparison

BIO

Bio Rad Laboratories Inc

FTRE

Fortrea Holdings Inc

Market Cap

BIO$9.80B

FTRE$1.98B

Enterprise Value

BIO$10.49B

FTRE$2.87B

Price

BIO$366.16

FTRE$20.84

P/E Ratio

BIO44.15x

FTREN/A

P/S Ratio

BIO3.78x

FTRE0.74x

EV/Sales

BIO4.05x

FTRE1.07x

EV/EBITDA

BIO15.48x

FTRE27.52x

P/B Ratio

BIO1.38x

FTRE3.63x

P/FCF Ratio

BIO27.75x

FTRE10.11x

EV/FCF

BIO29.69x

FTRE14.63x

PEG Ratio

BION/A

FTREN/A

Forward P/E (NTM)

BIO33.67x

FTRE21.43x

Forward P/S (NTM)

BIO3.70x

FTRE0.72x

Revenue (TTM)

BIO$2.59B

FTRE$2.68B

Revenue Growth (YoY)

BIO1.4%

FTRE-2.1%

Forward Rev Growth

BIO2.9%

FTRE3.1%

Gross Margin (TTM)

BIO51.9%

FTRE19.3%

Operating Margin (TTM)

BIO1.8%

FTRE0.0%

EBITDA Margin (TTM)

BIO9.1%

FTRE3.9%

Net Margin (TTM)

BIO8.6%

FTRE-3.2%

FCF Margin (TTM)

BIO13.6%

FTRE7.3%

Net Income (TTM)

BIO$222M

FTRE$-85M

FCF (TTM)

BIO$353M

FTRE$196M

EPS (TTM)

BIO$8.29

FTRE-$0.90

ROE (TTM)

BIO3.1%

FTRE-1553.0%

ROA (TTM)

BIO2.2%

FTRE-314.0%

ROIC (TTM)

BIO2.7%

FTRE-526.0%

Cash

BIO$517M

FTRE$169M

Debt

BIO$1.20B

FTRE$1.05B

Net Cash/Debt

BIO$-687M

FTRE$-886M

Current Ratio (TTM)

BIO3.14x

FTRE0.96x

Quick Ratio (TTM)

BIO2.18x

FTRE0.85x

Debt/Equity (TTM)

BIO0.17x

FTRE2.01x

Debt/Assets (TTM)

BIO0.0%

FTRE0.0%

Interest Coverage (TTM)

BION/A

FTREN/A

Net Debt/EBITDA (TTM)

BIO0.00x

FTRE0.00x

Beta

BIO1.07

FTRE1.93

52W Performance

BIO20.9%

FTRE105.7%

YTD Performance

BIO19.9%

FTRE24.0%

% from 52W High

BIO-7.6%

FTRE-11.4%

% from 52W Low

BIO54.7%

FTRE143.7%

Asset Turnover (TTM)

BIO0.26x

FTRE0.99x

FCF Yield (TTM)

BIO3.6%

FTRE9.9%

Earnings Yield (TTM)

BIO2.3%

FTRE-4.3%

Dividend Yield (TTM)

BION/A

FTREN/A

Rule of 40

BIO15.0

FTRE5.2

EV/GP/RG

BIO1.18

FTRE1.88

Ticker research

View BIO research View FTRE research

Metric	BIO Bio Rad Laboratories Inc	FTRE Fortrea Holdings Inc
Market & Valuation
Market Cap	$9.80B	$1.98B
Enterprise Value	$10.49B	$2.87B
Price	$366.16	$20.84
P/E Ratio	44.15x	N/A
P/S Ratio	3.78x	0.74x
EV/Sales	4.05x	1.07x
EV/EBITDA	15.48x	27.52x
P/B Ratio	1.38x	3.63x
P/FCF Ratio	27.75x	10.11x
EV/FCF	29.69x	14.63x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	33.67x	21.43x
Forward P/S (NTM)	3.70x	0.72x
Revenue & Growth
Revenue (TTM)	$2.59B	$2.68B
Revenue Growth (YoY)	1.4%	-2.1%
Forward Rev Growth	2.9%	3.1%
Profitability
Gross Margin (TTM)	51.9%	19.3%
Operating Margin (TTM)	1.8%	0.0%
EBITDA Margin (TTM)	9.1%	3.9%
Net Margin (TTM)	8.6%	-3.2%
FCF Margin (TTM)	13.6%	7.3%
Net Income (TTM)	$222M	$-85M
FCF (TTM)	$353M	$196M
EPS (TTM)	$8.29	-$0.90
ROE (TTM)	3.1%	-1553.0%
ROA (TTM)	2.2%	-314.0%
ROIC (TTM)	2.7%	-526.0%
Financial Health
Cash	$517M	$169M
Debt	$1.20B	$1.05B
Net Cash/Debt	$-687M	$-886M
Current Ratio (TTM)	3.14x	0.96x
Quick Ratio (TTM)	2.18x	0.85x
Debt/Equity (TTM)	0.17x	2.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.93
52W Performance	20.9%	105.7%
YTD Performance	19.9%	24.0%
% from 52W High	-7.6%	-11.4%
% from 52W Low	54.7%	143.7%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.99x
FCF Yield (TTM)	3.6%	9.9%
Earnings Yield (TTM)	2.3%	-4.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	15.0	5.2
EV/GP/RG	1.18	1.88
Ticker research	View BIO research	View FTRE research

Valuation

P/E Ratio

BIO

44.15x

P/S Ratio

FTRE

0.74x

BIO

3.78x

EV/FCF

FTRE

14.63x

BIO

29.69x

Growth & revenue

Revenue Growth TTM

BIO

1.4%

FTRE

-2.1%

Forward Revenue Growth

FTRE

3.1%

BIO

2.9%

Profitability & performance

Gross Margin

BIO

51.9%

FTRE

19.3%

ROE

BIO

3.1%

FTRE

-1553.0%

FCF Yield %

FTRE

9.9%

BIO

3.6%

52-Week Performance

FTRE

105.7%

BIO

20.9%

Detailed metrics comparison

BIO

Bio Rad Laboratories Inc

FTRE

Fortrea Holdings Inc

Market Cap

BIO$9.80B

FTRE$1.98B

Enterprise Value

BIO$10.49B

FTRE$2.87B

Price

BIO$366.16

FTRE$20.84

P/E Ratio

BIO44.15x

FTREN/A

P/S Ratio

BIO3.78x

FTRE0.74x

EV/Sales

BIO4.05x

FTRE1.07x

EV/EBITDA

BIO15.48x

FTRE27.52x

P/B Ratio

BIO1.38x

FTRE3.63x

P/FCF Ratio

BIO27.75x

FTRE10.11x

EV/FCF

BIO29.69x

FTRE14.63x

PEG Ratio

BION/A

FTREN/A

Forward P/E (NTM)

BIO33.67x

FTRE21.43x

Forward P/S (NTM)

BIO3.70x

FTRE0.72x

Revenue (TTM)

BIO$2.59B

FTRE$2.68B

Revenue Growth (YoY)

BIO1.4%

FTRE-2.1%

Forward Rev Growth

BIO2.9%

FTRE3.1%

Gross Margin (TTM)

BIO51.9%

FTRE19.3%

Operating Margin (TTM)

BIO1.8%

FTRE0.0%

EBITDA Margin (TTM)

BIO9.1%

FTRE3.9%

Net Margin (TTM)

BIO8.6%

FTRE-3.2%

FCF Margin (TTM)

BIO13.6%

FTRE7.3%

Net Income (TTM)

BIO$222M

FTRE$-85M

FCF (TTM)

BIO$353M

FTRE$196M

EPS (TTM)

BIO$8.29

FTRE-$0.90

ROE (TTM)

BIO3.1%

FTRE-1553.0%

ROA (TTM)

BIO2.2%

FTRE-314.0%

ROIC (TTM)

BIO2.7%

FTRE-526.0%

Cash

BIO$517M

FTRE$169M

Debt

BIO$1.20B

FTRE$1.05B

Net Cash/Debt

BIO$-687M

FTRE$-886M

Current Ratio (TTM)

BIO3.14x

FTRE0.96x

Quick Ratio (TTM)

BIO2.18x

FTRE0.85x

Debt/Equity (TTM)

BIO0.17x

FTRE2.01x

Debt/Assets (TTM)

BIO0.0%

FTRE0.0%

Interest Coverage (TTM)

BION/A

FTREN/A

Net Debt/EBITDA (TTM)

BIO0.00x

FTRE0.00x

Beta

BIO1.07

FTRE1.93

52W Performance

BIO20.9%

FTRE105.7%

YTD Performance

BIO19.9%

FTRE24.0%

% from 52W High

BIO-7.6%

FTRE-11.4%

% from 52W Low

BIO54.7%

FTRE143.7%

Asset Turnover (TTM)

BIO0.26x

FTRE0.99x

FCF Yield (TTM)

BIO3.6%

FTRE9.9%

Earnings Yield (TTM)

BIO2.3%

FTRE-4.3%

Dividend Yield (TTM)

BION/A

FTREN/A

Rule of 40

BIO15.0

FTRE5.2

EV/GP/RG

BIO1.18

FTRE1.88

Ticker research

View BIO research View FTRE research

Metric	BIO Bio Rad Laboratories Inc	FTRE Fortrea Holdings Inc
Market & Valuation
Market Cap	$9.80B	$1.98B
Enterprise Value	$10.49B	$2.87B
Price	$366.16	$20.84
P/E Ratio	44.15x	N/A
P/S Ratio	3.78x	0.74x
EV/Sales	4.05x	1.07x
EV/EBITDA	15.48x	27.52x
P/B Ratio	1.38x	3.63x
P/FCF Ratio	27.75x	10.11x
EV/FCF	29.69x	14.63x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	33.67x	21.43x
Forward P/S (NTM)	3.70x	0.72x
Revenue & Growth
Revenue (TTM)	$2.59B	$2.68B
Revenue Growth (YoY)	1.4%	-2.1%
Forward Rev Growth	2.9%	3.1%
Profitability
Gross Margin (TTM)	51.9%	19.3%
Operating Margin (TTM)	1.8%	0.0%
EBITDA Margin (TTM)	9.1%	3.9%
Net Margin (TTM)	8.6%	-3.2%
FCF Margin (TTM)	13.6%	7.3%
Net Income (TTM)	$222M	$-85M
FCF (TTM)	$353M	$196M
EPS (TTM)	$8.29	-$0.90
ROE (TTM)	3.1%	-1553.0%
ROA (TTM)	2.2%	-314.0%
ROIC (TTM)	2.7%	-526.0%
Financial Health
Cash	$517M	$169M
Debt	$1.20B	$1.05B
Net Cash/Debt	$-687M	$-886M
Current Ratio (TTM)	3.14x	0.96x
Quick Ratio (TTM)	2.18x	0.85x
Debt/Equity (TTM)	0.17x	2.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.93
52W Performance	20.9%	105.7%
YTD Performance	19.9%	24.0%
% from 52W High	-7.6%	-11.4%
% from 52W Low	54.7%	143.7%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.99x
FCF Yield (TTM)	3.6%	9.9%
Earnings Yield (TTM)	2.3%	-4.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	15.0	5.2
EV/GP/RG	1.18	1.88
Ticker research	View BIO research	View FTRE research